Navigation Links
ALPCO Announces the Launch of Rat and Mouse Proinsulin ELISA Kits
Date:1/26/2010

SALEM, N.H., Jan. 26 /PRNewswire/ -- ALPCO Diagnostics has developed two new low-sample volume ELISAs for the quantitative analysis of total proinsulin (I and II) in rats and mice.  These methods were developed using synthetic rat and mouse proinsulin I and II expressed in bacteria and purified from inclusion bodies, and were first introduced in an abstract presented at the Upper Midwest Islet Club Meeting in June 2009.

Both the Rat Proinsulin ELISA and Mouse Proinsulin ELISA allow for the direct quantification of total proinsulin (I & II) in serum.  Each kit requires only 10 microlitres of serum, giving researchers the opportunity to measure multiple analytes from a single sample collection.  The evaluation of a representative sample population of commonly used mouse and rat strains showed that > 90% of samples fell within the dynamic range of the respective assays, illustrating their utility in the field.  

A hallmark of these new assay systems are their defined cross reactivity with both proinsulin I and II.  Peter Wunderli, PhD, Laboratory Operations Manager at ALPCO, remarks on the significance of this advancement, "Rat proinsulin, as for mouse, is expressed as two isoforms. No one knows whether isoform expression is individually influenced by the disease.  Until that is established, there is a need to be able to measure the total proinsulin.  Our kits do that with excellent specificity and robustness."  

Several factors, not the least of which being the variability in expression of proinsulin I and II between mice and rats, makes the ALPCO species-specific assay kits the most attractive option for researchers expecting to quantify total proinsulin in their pre-clinical models.

While research has established that the total ratio of circulating proinsulin relative to insulin and c-peptide is altered in the diabetic and pre-diabetic state in humans, multiple barriers in the ability to accurately measure rodent proinsulin means relatively limited data has been available regarding concentrations of this molecule in rats and mice, both of which are widely used models in the diabetes research community.  

Craig LaMarca, a scientist and technical sales advisor with ALPCO, stated: "Typically in humans, proinsulin is elevated as a result of impaired processing in the beta cell, which is a characteristic of type 2 diabetes.  In cases of beta cell dysfunction, including type 2 diabetes and pre-diabetes, the proinsulin secretion ratio can increase to >60% (from 5% in a non-diabetic state).  Until now, there has not been a viable method for measuring rodent proinsulin, which would allow researchers to establish models for testing targeted therapies or interventions in the pre-clinical setting.  This new ELISA will open doors for a number of basic science research studies."  Dr. Wunderli added, "While these assays are exclusively for research use, ALPCO's development process addresses the diabetes research community's need for quality and consistency, which is necessary to ensure that the data can be applied to animal studies aimed at both aiding our understanding of the disease etiology and the effectiveness of experimental treatments. 

ALPCO has been manufacturing and distributing robust, well-characterized and user-friendly ELISA methods tailored to meet the unique demands of the metabolic disease research community since 1990.  

Contact: Kate Kaplan, 800-592-5726

SOURCE ALPCO

RELATED LINKS
http://www.alpco.com

'/>"/>

SOURCE ALPCO
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. ALPCO Launches GLP-1 (Active 7-36) and (7-36 and 9-36) ELISA Kits
2. Roxane Laboratories, Inc. Announces the New Drug Application Approval of Morphine Sulfate Oral Solution CII, 100mg/5mL (20mg/mL)
3. Brean Murray, Carret & Co. Announces 2010 Healthcare 1x1 Conference
4. MDS Announces Resolution of Litigation Related to the Sale of MDS Analytical Technologies
5. Agilux Laboratories Announces the Launch of GLP LC/MS/MS Bioanalytical Services
6. ORCS Web, Inc Announces Plans for Employee Ownership
7. Eyre Bus, Tour & Travel Donates Bus to Transport Medical Professionals from D.C. Area to New York for Flight to Haiti, Announces the Greater Washington Haiti Relief Committee and the Embassy of Haiti
8. Forterus Announces Fiscal Year 2009 Financial Results
9. UCLB announces new partnership with Kurma Biofund
10. AXIOM Systems, Inc. Announces General Release of HIPAA 5010 Testing Solutions
11. Universal Health Services, Inc. Announces Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... While it’s often important to take ... an inventor from Austin, Texas, has identified a solution. , She developed a prototype ... restricted lighting. As such, it eliminates the need to turn on a light when ...
(Date:10/13/2017)... Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD ... dose required and providing a CBD form that can be easily incorporated into liquid ...
(Date:10/13/2017)... ... , ... Apple Rehab Shelton Lakes , which specializes in the delivery ... as part of a disaster drill on October 3rd. , Apple Rehab participated with ... Manager, as well as the Connecticut Long Term Care Mutual Aid Plan (LTC-MAP). ...
(Date:10/13/2017)... ... 2017 , ... Ellevate Network, the leading network for professional women, brought together ... equality at their inaugural Summit in New York City in June. The event was ... of over 3 million. To watch the Mobilize Women video, click here . ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob Lowe, ... in a new episode of "Success Files," which is an award-winning educational program ... investigates each subject in-depth with passion and integrity. , Sciatica occurs when the ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and Company ... results for the third quarter of 2017 on Tuesday, ... call on that day with the investment community and ... The conference call will begin at 9 a.m. ... access a live webcast of the conference call through ...
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile ... the struggle to reverse the tide of prescription drug addiction. ... regulating their medicine intake and stepping down their dosage in ... to launch in December 2017; the first 100,000 people to ... more at http://www.rebound-solution.com/ ...
(Date:9/27/2017)... -- Commended for their devotion to personalized service, SMP Pharmacy Solutions ... in the South Florida Business Journal,s 50 Fastest-Growing Companies, and ... the national specialty pharmacy has found its niche.  To that ... be honored by SFBJ as the 2017 Power Leader in ... receive his award in October, Bardisa said of the three ...
Breaking Medicine Technology: